Early-Development Strategy for PTE in Biologics Given Unknowns in the Law
Published: | Updated:
The importance of early development strategy and planning for biologic patent term extension.
Micheal Binns
Advertisement
Articles by Micheal Binns
Advertisement
Latest Updated Articles
- Early-Development Strategy for PTE in Biologics Given Unknowns in the Law
Published: July 3rd 2018 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Pharmaceutical Executive Daily: FDA Approves Hernexeos
3
FDA Approves Dupixent as First Treatment for Allergic Fungal Rhinosinusitis in Adults and Children
4
FDA Approves Hernexeos Under National Priority Voucher Program
5